US2017333372A1PendingUtilityA1
Compositions for improvement of brain function
Est. expirySep 19, 2032(~6.2 yrs left)· nominal 20-yr term from priority
Inventors:Stefan Pierzynowski
A61P 43/00A61P 9/10A61P 25/24A61P 27/02A61P 25/22A61P 25/14A61P 3/02A61P 25/18A61P 25/28A61P 25/16A61K 31/198A61K 38/465A61K 38/48A61K 38/47A61P 21/00A61K 31/194A61P 25/00C12Y 302/01001A61K 38/54A61K 45/06
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition comprising alpha-ketoglutaric acid or a pharmaceutically acceptable salt thereof (AKG), and one or more enzymes selected from a group consisting of a lipase, a protease and an amylase, and medical uses thereof in, neurological and/or neurodegenerative disease, neurological trauma, depression or chronic fatigue syndrome.
Claims
exact text as granted — not AI-modified1 . A composition comprising alpha-ketoglutaric acid or a pharmaceutically acceptable salt thereof (AKG), and one or more enzymes selected from the group consisting of lipases, proteases and amylases.
2 . A method of treatment for a disease, comprising administering a composition comprising alpha-ketoglutaric acid or a pharmaceutically acceptable salt thereof (AKG), and one or more enzymes selected from the group consisting of lipases, proteases and amylases to a subject in need thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.